about
Understanding the population genetics of Plasmodium vivax is essential for malaria control and eliminationPlasmodium malariae and Plasmodium ovale--the "bashful" malaria parasitesGenome-wide and fine-resolution association analysis of malaria in West AfricaEliminating the Neglected Tropical Diseases: Translational Science and New Technologies.Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New GuineaImplications of Plasmodium vivax Biology for Control, Elimination, and ResearchRifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trialIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialReduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studySkeleton-binding protein 1 functions at the parasitophorous vacuole membrane to traffic PfEMP1 to the Plasmodium falciparum-infected erythrocyte surfaceTargeted mutagenesis of Plasmodium falciparum erythrocyte membrane protein 3 (PfEMP3) disrupts cytoadherence of malaria-infected red blood cellsBuilding coherence and synergy among global health initiatives.The heterosexual HIV type 1 epidemic in Papua New Guinea is dominated by subtype C.Building Global Capacity for Conducting Operational Research Using the SORT IT Model: Where and Who?The need for operational research and capacity-building in support of the Global Technical Strategy for Malaria 2016-2030.Open access for operational research publications from low- and middle-income countries: who pays?Transcription of multiple var genes by individual, trophozoite-stage Plasmodium falciparum cells expressing a chondroitin sulphate A binding phenotype.New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates.Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia.Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.Molecular epidemiology of Plasmodium falciparum resistance to antimalarial drugs in Indonesia.Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparumPopulation hemoglobin mean and anemia prevalence in Papua New Guinea: new metrics for defining malaria endemicity?Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.Identification of glycosaminoglycan binding domains in Plasmodium falciparum erythrocyte membrane protein 1 of a chondroitin sulfate A-adherent parasitePlasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmissionPlasmodium falciparum erythrocyte membrane protein 1 functions as a ligand for P-selectin.Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populationsParasite adhesion and immune evasion in placental malaria.Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission.Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress.Adhesion of Plasmodium falciparum-infected red blood cells to CD36 under flow is enhanced by the cerebral malaria-protective trait South-East Asian ovalocytosis.Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New GuineaPlasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaSafety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trialA changing model for developing health products for poverty-related infectious diseasesApplied research for better disease prevention and control.What have we learned from 40 years of supporting research and capacity building?
P50
Q17485678-E0E42AD8-09BD-486B-8DE8-8897E5E6792CQ21032489-9BA8C9F3-0941-442A-8AFE-3C79DCBD1BACQ24632119-CC82D068-5DD7-4C9C-A347-95EC40083C26Q26765026-85EDC4A2-F8AB-4E5E-A61D-235EE62EF445Q28217640-7CC47E12-558B-4E78-89AF-875306FCF892Q28355362-FCAA94BE-355B-4C2B-8115-951AF884614FQ28469083-6A974C83-9D40-4583-9055-A8519CA4EF60Q28481649-E53F6378-9BC0-441E-8D4C-48B5A31C23ECQ28483318-67C28F97-FD94-4C11-A459-98BA0F2C79C3Q30038747-27D1814A-11D0-47BD-A318-F65DC2197896Q30039199-F7B6FC3B-30FA-4A19-8149-DE2457751CFEQ30062096-0C7329EA-8F04-484E-B79D-D6418635C608Q30363248-F63BF7F8-4409-4A22-9BA0-D2A169700B7CQ30382118-48C7C9BA-6AB8-46E6-AE10-722583E2138BQ30384988-B5F49F87-8934-40A3-AA80-6D3C0D051F68Q30488364-C753B781-6053-47A7-A708-FCDFFC43EBDCQ30828703-CAD15105-5B60-48DA-BAD8-90E1C188EEE3Q30967506-1423625F-5522-4176-8548-400974A63E0BQ30984906-909878A2-34BF-44AA-9A8D-330EF2806A30Q31143848-54DFDCC6-C822-434E-AE75-17110A311487Q31150710-76A745C2-6C70-481C-872B-E140C889D7CBQ33344896-AB9D5626-B25D-4807-97CB-A8894D240F13Q33521214-EB548B37-984C-4F2D-B60B-9BDCFEB1A7AFQ33535802-246FA057-E85E-405B-8A5C-D5A793F94C98Q33558449-530AEADC-F911-4442-A40C-488B25E959DDQ33596242-108BACA9-90B7-4F98-A990-07C9E32C7A98Q33645352-7B295CF8-EB42-4246-80C7-B401FEDD338FQ33859217-FBFBE45D-2C06-48AF-AC7A-2FB705A4067DQ34100761-D19D319C-5278-4EAD-BB1A-A4C612BDFA52Q34163026-7FD6C144-F096-44F5-A884-39AF58D053B5Q34292107-BDA9872D-E884-4CA6-89AC-F4F835A9BED9Q34408419-B206DB34-AC98-4323-8BBE-02E8897FBB89Q34422119-C83B7E01-669F-456F-8A1A-D3B7DA233BDBQ34429002-C586B863-351D-4914-AE65-FA331A7C1DECQ34509744-BEA06560-2AB7-4FED-A9D8-6AF47250FD11Q34596548-B4DE8793-C1DF-4DC5-97F3-D825C3ED1110Q34602513-5EA4B039-93AE-42F0-B16E-389026F21958Q34874306-0B5D3219-340A-4407-895B-B43D928A355DQ34874760-70679E18-C8FB-44C1-8686-8B2DB6086C35Q34874787-E62D6F24-834B-400A-8585-9A34A6F8EB64
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John C Reeder
@ast
John C Reeder
@en
John C Reeder
@es
John C Reeder
@nl
John C Reeder
@sl
type
label
John C Reeder
@ast
John C Reeder
@en
John C Reeder
@es
John C Reeder
@nl
John C Reeder
@sl
altLabel
John C Reeder
@en
Reeder J
@en
Reeder JC
@en
Reeder John C
@en
Reeder John
@en
prefLabel
John C Reeder
@ast
John C Reeder
@en
John C Reeder
@es
John C Reeder
@nl
John C Reeder
@sl
P106
P21
P31
P496
0000-0003-1395-1289